OrthoPediatrics (NASDAQ:KIDS) Earns Buy Rating from BTIG ResearchMarket Beat·2 days ago, 12:06 PMKIDS-5.92%
OrthoPediatrics director, 10% owner David R. Pelizzon disposes of USD 6.35 million in common sharesPUBT·Sep 10 at 08:22 PMKIDS-5.92%
OrthoPediatrics (NASDAQ:KIDS) Sees Strong Trading Volume - What's Next?Market Beat·Sep 10 at 04:40 PMKIDS-5.92%
OrthoPediatrics director, 10% owner David R. Pelizzon disposes of 22,500 shares worth $525,375PUBT·Sep 4 at 08:27 PMKIDS-5.92%
OrthoPediatrics (NASDAQ:KIDS) Director David Pelizzon Sells 10,131 Shares of StockMarket Beat·Sep 2 at 09:23 AMKIDS-5.92%GS+1.44%
OrthoPediatrics director, 10% owner David R. Pelizzon disposes of 336,831 common shares worth $7.76 millionPUBT·Sep 1 at 09:14 PMKIDS-5.92%
OrthoPediatrics Director David R. Pelizzon reports disposal of common shares worth $939,792.5PUBT·Aug 26 at 10:18 PMKIDS-5.92%
OrthoPediatrics Announces Full Commercial Launch of 3P™ Pediatric Plating Platform® Hip System Following More Than 350 Successful Implantations | KIDS Stock NewsStockTitan·Aug 25 at 03:05 AMKIDS-5.92%
OrthoPediatrics (NASDAQ:KIDS) Shares Down 3.7% - Here's What HappenedMarket Beat·Aug 21 at 07:20 PMKIDS-5.92%
OrthoPediatrics (NASDAQ:KIDS) Sets New 1-Year High - Here's WhyMarket Beat·Aug 18 at 06:20 PMKIDS-5.92%BLK+1.61%
OrthoPediatrics Sees ‘Inflection Point’ as New Products Fuel Record QuarterMarket Beat·Aug 14 at 10:04 PMKIDS-5.92%
KIDS: Record Q2, robust pipeline, and global expansion set the stage for sustained profitable growthQuartr·Aug 12 at 03:00 PMKIDS-5.92%
OrthoPediatrics (NASDAQ:KIDS) Sets New 12-Month High on Analyst UpgradeMarket Beat·Aug 6 at 02:20 PMKIDS-5.92%
